211
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

5-Fluorouracil, capecitabine and vasospasm: a scoping review of pathogenesis, management options and future research considerations

, ORCID Icon, , , , & show all
Pages 1-13 | Received 12 Nov 2020, Accepted 04 Jan 2021, Published online: 08 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hongtao Li, Rongfang Shan, Jiaxiang Ding, Jialin Zhang, Bingyan Liu, Qin Ge, Dongmei Cheng, Lufeng Li, Chaoyang Zhang, He Su, Xiaoyue Li, Huiru Li, Jingjing Ye, Hui Li, Fengxian Li, Huan Zhou, Qiang Huo & Yue Su. (2023) Evaluation of bioequivalence and safety analysis of capecitabine tablets and Xeloda® under postprandial dosing conditions in Chinese patients with solid tumor. Expert Opinion on Drug Metabolism & Toxicology 19:12, pages 1015-1021.
Read now

Articles from other publishers (3)

Mohsen Rajaeinejad, Peyvand Parhizkar-Roudsari, Mehran Khoshfetrat, Mohammad Hassan Kazemi-galougahi, Reza Mosaed, Rasta Arjmand, Seyed Abolfazl Mohsenizadeh & Babak Arjmand. (2024) Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment. Cardiovascular Toxicology 24:2, pages 184-198.
Crossref
Toufik Abdul-Rahman, Alden Dunham, Helen Huang, Syed Muhammad Awais Bukhari, Aashna Mehta, Wireko A. Awuah, Deba Ede-Imafidon, Emiliano Cantu-Herrera, Suprateeka Talukder, Amogh Joshi, Deborah W. Sundlof & Rahul Gupta. (2023) Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics. Current Problems in Cardiology 48:4, pages 101591.
Crossref
I.  P. Kolos, V. A. Chernyshova  , E.  V. Konstantinova & M.  Yu. Gilyarov. (2022) Capecitabine and vasospastic angina: a clinical case. Kardiologiia 62:2, pages 36-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.